Nature 415, 92–96 (2002).
In this Letter, the commercial polyclonal antiserum used to detect endogenous XBP-1 was sc-7160 (Santa Cruz Biotechnology) and not sc-8015, as erroneously stated. The antibody sc-8015 is a mouse monoclonal and, in our hands, is not useful in detecting the endogenous protein by immunoblotting.
Additional information
The online version of the original article can be found at 10.1038/415092a
Rights and permissions
About this article
Cite this article
Calfon, M., Zeng, H., Urano, F. et al. Correction: Corrigendum: IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA. Nature 420, 202 (2002). https://doi.org/10.1038/nature01193
Issue Date:
DOI: https://doi.org/10.1038/nature01193
This article is cited by
-
Dual RNase activity of IRE1 as a target for anticancer therapies
Journal of Cell Communication and Signaling (2023)
-
Harnessing the power of genetics: fast forward genetics in Caenorhabditis elegans
Molecular Genetics and Genomics (2021)
-
Merits and pitfalls of conventional and covalent docking in identifying new hydroxyl aryl aldehyde like compounds as human IRE1 inhibitors
Scientific Reports (2019)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
